GlassScriptPhysician profile
Thirupath Reddy
NPI 1992808992
$36,284.71
in general payments reported to CMS, 2019-2025
30 companies · $5,041 in 2025
The $5,041 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,400 · 2020: $2,450 · 2021: $2,111 · 2022: $3,831 · 2023: $4,495 · 2024: $13K · 2025: $5,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Consulting Fee: $4,675 · Food and Beverage: $3,031 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,686.34 |
| Consulting Fee | $4,675.00 |
| Food and Beverage | $3,031.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $13,537.05 | 2019-2025 | Solia, Selectra, Acticor 7 Vr-T Dx |
| Medtronic, INC. | $12,759.27 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Selectsecure |
| Medtronic Vascular, INC. | $5,634.53 | 2019-2020 | |
| Abbott Laboratories | $1,770.98 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Astrazeneca Pharmaceuticals LP | $343.34 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $273.39 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $233.33 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.37 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $192.15 | 2019-2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $186.93 | 2019-2024 | Xarelto |
| Amgen INC. | $167.97 | 2019-2024 | Repatha |
| Novo Nordisk INC | $153.35 | 2022-2025 | Wegovy |
| Pfizer INC. | $149.55 | 2019-2025 | |
| Lilly USA, LLC | $140.72 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $112.38 | 2021-2025 | Capvaxive |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $74.27 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $42.64 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.89 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $34.78 | 2022 | |
| Angiodynamics, INC. | $32.24 | 2021 | |
| Tactile Systems Technology INC | $26.06 | 2024 | Flexitouch Plus, Entre Plus |
| Atricure, INC. | $23.31 | 2023 | |
| Glaxosmithkline, LLC. | $22.65 | 2023 | Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $20.11 | 2025 | |
| Baxter Healthcare | $17.79 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Octapharma USA, INC. | $17.51 | 2025 | Balfaxar |
| Medicomp INC | $17.41 | 2022 | |
| Edwards Lifesciences Corporation | $17.15 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Paratek Pharmaceuticals, INC. | $15.57 | 2022 | |
| Alnylam Pharmaceuticals INC. | $14.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thirupath Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.